Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib in Endometrial Serous Carcinoma
NCT04716686Phase 2Recruiting
- Sponsor
- Shandong University
- Start
- Jun 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in endometrial carcinoma, serous endometrial carcinoma (USC), sponsored by Shandong University. Started Jun 2021; status: recruiting.
02
Drugs
niraparib
03
Conditions
endometrial carcinomaserous endometrial carcinoma (USC)
Beyond the preview
Go deeper on NCT04716686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04716686.